why choose us

First received: December 28, 2022

Clinical Trial: Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gallstone Disease

Study Type: OBSERVATIONAL


Official Title: Observational Study of Efficiency of the Drug Remaxol® (Inosine + Meglumine + Methionine + Nicotinamide + Succinic Acid) Used in the Treatment of Patients With Gallstone Disease Complicated With Obstr

Brief Summary: Obstructive jaundice is observed in 10-80 % of gallstone disease cases.The conventional tactics for the management of patients with obstructive jaundice is to remove biliary hypertension by using endoscopic or minimally invasive methods.The final surgical treatment is performed after jaundice reduction and normalization of hepatic functions.We suppose that the administration of the drug Remaxol (Inosine + Meglumine + Methionine + Nicotinamide + Succinic acid) during the perioperative period shortens jaundice…

Read more